Elbahnasy A M, Hoenig D M, Shalhav A, McDougall E M, Clayman R V
Department of Surgery, Washington University School of Medicine, St. Louis, Missouri 63110, USA.
J Endourol. 1998 Feb;12(1):55-9. doi: 10.1089/end.1998.12.55.
Since the first laparoscopic pelvic lymph node dissection (LPLND) was performed for prostate cancer, only one case of port site metastasis has been reported, an incidence of 0.1%. On the other hand, three cases of port site metastasis have been reported after laparoscopic staging of transitional-cell carcinoma (TCC) of the bladder, a reported incidence of almost 4%. Herein, we review the circumstances of these three cases and address the potential risk factors and possible preventive measures regarding LPLND and port site metastasis in patients with TCC of the bladder.
自从首次对前列腺癌进行腹腔镜盆腔淋巴结清扫术（LPLND）以来，仅报告了1例切口部位转移病例，发生率为0.1%。另一方面，在对膀胱移行细胞癌（TCC）进行腹腔镜分期后，已报告了3例切口部位转移病例，报告发生率近4%。在此，我们回顾这3例病例的情况，并探讨膀胱TCC患者LPLND及切口部位转移的潜在危险因素和可能的预防措施。
